stockrowCabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- +79.4%
- Free cash flow
- −51.7%
- Total debt
- +10.8%
Quarter to September 2026, against a year earlier
Follow CBT
Alert me
Cabot Corporation (CBT) Revenue growth
Cabot Corporation's revenue growth over the twelve months to 30 September 2026 was 0.83%, up 7.9 percentage points from fiscal 2025 (−7.04%). Over the past ten years it has ranged from −21.7% (fiscal 2020) to 30.4% (fiscal 2021); the current reading is higher than 45% of that period. That is below the Specialty Chemicals industry median of 6.39% and below the Basic Materials sector median of 9.54%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | −7.04% | (8.64) |
| FY2024 | 1.60% | 10.63 |
| FY2023 | −9.03% | (35.78) |
| FY2022 | 26.8% | (3.66) |
| FY2021 | 30.4% | 52.08 |
| FY2020 | −21.7% | (24.60) |
| FY2019 | 2.93% | (16.39) |
| FY2018 | 19.3% | 6.63 |
| FY2017 | 12.7% | 28.71 |
| FY2016 | −16.0% | 5.26 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 12.2% | 5.85 |
| Jun 2026 | 6.39% | 9.81 |
| Mar 2026 | −3.42% | 7.68 |
| Dec 2025 | −11.1% | (0.91) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PRM Perimeter Solutions, SA compare | 30.7% |
| CLMT Calumet, Inc. compare | 12.8% |
| WDFC WD-40 Company compare | 11.0% |
| SXT Sensient Technologies Corporation compare | 9.54% |
| HWKN Hawkins, Inc. compare | 9.02% |
| AVNT Avient Corporation compare | 5.24% |
| ASH Ashland Inc. compare | 2.14% |
| FUL H. B. Fuller Company compare | 1.48% |
| CBT Cabot Corporation | 0.83% |
| Specialty Chemicals industry median | 6.39% |
| Basic Materials sector median | 9.54% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on CBT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement